Stimulants

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

According to the CDC, from 2012 through 2020 in the United States, the number of deaths involving methamphetamine increased more than 6-fold while the number of deaths involving cocaine more than tripled. This session will focus on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more. 

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Novel Approaches to the Prevention and Treatment of Stimulant Use Disorders
  This presentation will summarize prevention and treatment recommendations from the new ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. Key takeaways from the guideline will be discussed. Topics for discussion will include behavioral and pharmacological treatments, co-occurring conditions, management of stimulant intoxication and withdrawal, and secondary and tertiary prevention strategies to reduce harms associated with risky stimulant use.
• Mosaic Approaches to Understanding ADHD and Stimulant Use Disorders
  This session provides an overview of ADHD, including diagnostic criteria and key characteristics, with a focus on understanding the overlap between ADHD and substance use disorders. Participants will explore methods to reduce stimulant misuse and examine the trajectories of substance use disorders in individuals with ADHD. The discussion will also highlight how the COVID-19 pandemic shifted diversion sources among adolescents and young adults, emphasizing the evolving nature of these challenges.
• BEAT Meth: New Findings for Advancing Methamphetamine Addiction Treatment
  The pathophysiology of methamphetamine addiction--including its intense biological reinforcement and symptom profile--poses challenges for prevention and treatment. Attendees will hear original findings from BEAT Meth, a CDC-funded project that applies a multifaceted public health approach to addressing methamphetamine addiction. These findings include strategies to describe methamphetamine-related healthcare utilization; diagnostic criteria for methamphetamine-induced psychotic disorders; and adaptation of contingency management to support linkage to care.
• Development of Dual-Acting Sigma and Dopamine Transporter Inhibitors as Potential Pharmacotherapy for Stimulant Use Disorders
  This session will describe a novel pharmacotherapy mechanism of treating stimulant use disorder.   The attendees will be able to explain the necessity for the dual mechanism of action in the drugs ability to attenuate rodents from self-administering cocaine.  This session will also demonstrate the success of this concept, the challenges that are still ahead with drug development, and the potential for this treatment to be game changing as an aid in the treatment of stimulant use disorders.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2 Credit(s)
• Nurses & NPs: 2 Nursing Contact Hour(s)
• Pharmacology Hour(s): 1.75 Hour(s)
• PAs: 2 Credit(s)
• Pharmacists: 2 Credit(s)
• Interprofessional Continuing Education: 2 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2 Lifelong Learning
• ABIM MOC Points: 2 Medical Knowledge
• ABP MOC: 2 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2 Accredited CME | 2 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Federal Agency Session

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

During this 1-hour, on-demand session from the 2024 ASAM State of the Art Course, federal agency leaders from NIAAA, SAMHSA, and NIDA give brief overviews about emerging issues and advances in addiction medicine from their respective organizations. Following the presentations, ASAM President, Dr. Brian Hurley, leads the agencies in a lively discussion about the most pressing topics in addiction medicine.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 1.00 Credit(s)
• Nurses & NPs: 1.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): Not offered
• PAs: 1.00 Credit(s)
• Pharmacists: 1.00 Credit(s)
• Interprofessional Continuing Education: 1.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 1.00 Lifelong Learning
• ABIM MOC Points: 1.00 Medical Knowledge
• ABP MOC: 1.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 1.00 Accredited CME | 1.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Cannabis

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Cannabis is the most used federally illegal drug in the United States. With a growing market and shrinking perception of harm among the general population, the last several years have seen a steady increase in research on cannabis and its relative benefits and harms. This session will outline recent interesting findings and topics that have emerged, from differences in formulations and routes of administration to ways research may impact the future of policy.

This session is comprised of 2 presentations and a panel that dive deep into different aspects of the overall topic.

• Using Human Laboratory Studies to Characterize the Effects of Novel Cannabis Products, Formulations, and Routes of Administration
  This session will showcase data from the Johns Hopkins Cannabis Science Lab which conducts controlled human dosing studies to understand the effects of cannabis. Research projects presented include systematic studies to characterize the impact of dose, route of administration, and product formulation, as well as studies designed to determine driving impairment associated with cannabis use.
• How Laboratory Science Can Inform Cannabis Use Prevention, Treatment, and Regulation
  This session will review current data on the use of cannabis in medical settings. These data will include an overview of the possible clinical benefits and adverse effects of cannabis. Topics covered will include drug-drug interactions with other medications, effects of acute and chronic cannabis on mental health and performance, and potential for abuse and dependence. Methods described will include laboratory assessments, real-world treatment tracking, and epidemiological data.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 1.00 Credit(s)
• Nurses & NPs: 1.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): Not offered
• PAs: 1.00 Credit(s)
• Pharmacists: 1.00 Credit(s)
• Interprofessional Continuing Education: 1.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 1.00 Lifelong Learning
• ABIM MOC Points: 1.00 Medical Knowledge
• ABP MOC: 1.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 1.00 Accredited CME | 1.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Nicotine

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Smoking remains the leading cause of preventable disease and death in the US, killing more than 480,000 Americans each year. Smoking cessation is possible and can save lives. This session will discuss tobacco use in different populations, GLP-1 use for smoking cessation, comparative effectiveness of treatment models, and more, to provide a comprehensive overview of the state of the art of treatment for nicotine use disorder. 

This session is comprised of 4 presentations and a panel that dive deep into different aspects of the overall topic.

• Adaptive Trials for Tobacco Cessation
  This session will review clinical trials testing the development or comparative effectiveness of adaptive tobacco cessation treatment models which adapt individual cessation treatment based on user response. The session will further explore the strengths and limitations of different trial designs and assess the generalizability of adaptive treatment research findings for use in clinical practice.
• GLP-1 Agonists for the Treatment of Nicotine Dependence and Post-Cessation Weight Management: The Skinny on Novel Anti-Obesity Medications
  Despite tremendous health benefits, smoking cessation leads to an increased consumption of highly palatable foods. As a result, the majority of former smokers gain weight after quitting. Post-cessation weight gain (PCWG) can decrease smoking cessation motivation and success, and it can have detrimental effects on metabolic health in those who do achieve abstinence. This presentation will focus on the potential utility of glucagon-like peptide 1 receptor agonists (GLP1-RA) for addressing tobacco smoking and post-cessation weight management.  The author will discuss the overall state of the science on targeting GLP-1Rs to reduce tobacco smoking and PCWG, with the primary focus on the completed and ongoing clinical trials conducted by our group. Directions for future clinical research will be provided.
• Tobacco Use among Older Adults: A Forgotten Population
  The number of adults 65 years and older is projected to nearly double between 2012 and 2050, prompting global efforts to address the inevitable challenges of this population shift. Of concern is the parallel observation that tobacco smoking prevalence in the US and other countries has declined considerably for all age groups except for those 65 and older. Given these trends, it is likely that the absolute number of older adults who smoke will increase in the coming years. This presentation will explore these trends and address older adults' interest in quitting and cessation rates. The presentation will also expand on the recently published ASAM Criteria (4th Ed) chapter on tobacco use, focusing on older adults and harm reduction approaches.
• Novel and Emerging Interventions for Patients Unwilling to Quit
  Smoking tobacco cigarettes is associated with premature mortality. Quitting smoking can help people gain between 3 to 10 Quality Adjusted Life Years (QALYs). However, even the best evidence-based treatments have low absolute quit rates. Repeated attempts are associated with greater success and should be encouraged. Unfortunately, some populations such as those with concurrent addictions and or mental illness are "treatment resistant". This session will present emerging evidence on novel and new interventions (e.g. brain stimulation) that could help them stop smoking cigarettes for good. In addition, this session will invite attendees to appraise the evidence for off-label use of existing treatments including combination, higher doses, extended treatment, and lower risk nicotine use guidelines.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2.00 Credit(s)
• Nurses & NPs: 2.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): .5 Hour(s)
• PAs: 2.00 Credit(s)
• Pharmacists: 2.00 Credit(s)
• Interprofessional Continuing Education: 2.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2.00 Lifelong Learning
• ABIM MOC Points: 2.00 Medical Knowledge
• ABP MOC: 2.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2.00 Accredited CME | 2.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Alcohol

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

According to 2023 national data, 10% of individuals ages 12 and older met criteria for an alcohol use disorder (AUD) in the past year. This indicates an urgent need for effective and innovative approaches to meet the needs of this large treatment population. This session will examine new research on AUD treatment, including spironolactone, psychedelics, GLP-1, and technology-assisted approaches.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Spironolactone in Alcohol Addiction: A Translational Approach
  This session will review recent work conducted in animal models, including mice, rats, and non-human primates, as well as recent work in humans, including in people with alcohol use disorder, that has been conducted on (1) the relationship between aldosterone and alcohol drinking and dependence, and (2) the potential role of spironolactone in alcohol use disorder.
• Psychedelics for the Treatment of Alcohol Use Disorder
  The session will describe  the results of completed trials of investigational psychedelic medications in the treatment to alcohol use disorder. Evidence for safety and efficacy will be evaluated, and possible mechanisms of action will be discussed based on currently available data. The prevention will also discuss possible next steps toward clinical use and safe and equitable dissemination of new treatments should they become available for clinical use.
• Repurposing the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide to Treat Alcohol Use Disorder
  Anecdotal reports of the efficacy of semaglutide and other Glucagon-Like Peptide-1 (GLP-1) receptor agonists as medical therapies for obesity have garnered widespread public attention, engendering ethical debates and leading to worldwide drug shortages.  This brief presentation will update participants about the National Institute on Drug Abuse Intramural Research Program's ongoing early phase clinical trial studying the exciting possibility of repurposing semaglutide to treat patients with alcohol use disorder.
• Technology-Assisted Approaches to Facilitate Remotely Delivered Alcohol Use Disorder Treatment
  This session will provide an overview of recent research that has involved remotely delivered alcohol use disorder treatment. Covered topics will include the key elements of treatment delivery that can be facilitated by technology, the types of devices and their features that have been useful for this research, and results from randomized clinical trials employing these techniques. Overall, results will demonstrate that technology-assisted approaches to alcohol use disorder treatment delivery can demonstrate high degrees of efficacy while overcoming some of the treatment-access barriers associated with in-person treatments.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2 Credit(s)
• Nurses & NPs: 2 Nursing Contact Hour(s)
• Pharmacology Hour(s): 1 Hour(s)
• PAs: 2 Credit(s)
• Pharmacists: 2 Credit(s)
• Interprofessional Continuing Education: 2 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2 Lifelong Learning
• ABIM MOC Points: 2 Medical Knowledge
• ABP MOC: 2 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2 Accredited CME | 2 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Innovations in Technology

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Recent innovations in addiction treatment technology are transforming clinical care. These advancements provide novel, personalized treatment options, facilitate real-time communication with healthcare providers, and promote engagement in recovery and harm reduction. This session will discuss new approaches such as tele-harm reduction, brain stimulation, and more.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Harnessing Digital Health in the Assessment and Treatment of Substance Use Disorders
  This session explores the role of digital health technologies in the assessment and treatment of substance use disorders. Attendees will learn about innovative digital tools that enhance screening accuracy, personalize treatment, and improve patient engagement. The discussion will cover the benefits, challenges, and ethical considerations of using digital health in clinical practice, as well as its potential to transform substance use care. 

• Tele-Harm Reduction
  This session will introduce Tele-Harm Reduction (THR) as a crucial and innovative tool towards ending the HIV epidemic. THR leverages telehealth technology to deliver comprehensive care within syringe services programs (SSPs). T-SHARP is a clinical trial that aims to improve HIV outcomes among people who inject drugs (PWID). The trial evaluates the efficacy of this telehealth intervention in achieving viral suppression, initiating medications for opioid use disorder (MOUD), and curing hepatitis C. By bridging the digital divide and meeting PWID where they are, T-SHARP seeks to transform HIV care delivery and improve clinical outcomes.
• Randomized Repetitive Transcranial Magnetic Stimulation Trial for Smoking Cessation
  A comparison of 1 Hz rTMS over the medial frontal cortex and 10 Hz rTMS over the dorsolateral prefrontal cortex was completed in healthy smokers. Results showed that 10 Hz rTMS reduced cigarette consumption more than 1 Hz rTMS as well as sham TMS. 10 Hz treatment increased brain activity in the lateral prefrontal cortex and decreased brain activity in the medial frontal cortex. The study demonstrates that 10 Hz rTMS stimulation of the dorsolateral prefrontal cortex in an executive control circuit may be better for developing brain stimulation treatment than 1Hz rTMS of the medial orbitofrontal cortex in a medial reward circuit.
• Primary and Secondary Findings from the NIDA CTN ADAPT-2 Trial in Relation to the Treatment of Methamphetamine Use Disorder
  This session will delve into the cutting-edge research and treatment options for stimulant use disorders. Participants will learn about the latest pharmacotherapy developments and the significance of biomarker research in enhancing treatment efficacy. The discussion will also cover the challenges faced in treating stimulant use disorders and propose innovative solutions. Overall, the session aims to provide a comprehensive understanding of the evolving landscape of stimulant use disorder treatments.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2.00 Credit(s)
• Nurses & NPs: 2.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): 0.5 Hour(s)
• PAs: 2.00 Credit(s)
• Pharmacists: 2.00 Credit(s)
• Interprofessional Continuing Education: 2.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2.00 Lifelong Learning
• ABIM MOC Points: 2.00 Medical Knowledge
• ABP MOC: 2.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2.00 Accredited CME | 2.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Maintaining Recovery

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Addiction is a chronic medical disease, and recovery looks different from traditional acute care models. This session will explore a contextual model of addiction recovery and delve into different tools that may support individuals in maintaining recovery including contingency management, expanded medication access, and culturally attuned interventions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• A Contextual Model of Addiction Recovery
  This session will review models of addiction and propose a more central role for the context as a determinant of behavior in addiction and recovery. Models of addiction, though reductive in nature, are communicated broadly to the public and impact perceptions of addiction, scientific priorities, clinical practice, and policy decisions. Brain disease, moral, and choice models account for some, but not all, of the phenomenology of addiction, and are mechanistically limited in scope. This session will outline contextual models of addiction and recovery, review empirical evidence supporting the role of context, and outline potential benefits of a contextual model at  the level of the individual and society in the areas of science, clinical practice, and policy.
• Contingency Management
  This session will review the goals of contingency management and the principles that underly the treatment approach.  This session will discuss the key metrics or elements that make up a contingency management intervention.  This session will review the evidence base that supports this treatment approach, with a particular focus on adolescents and the unique aspects to consider when using contingency management with youth.
• Expanding Methadone Access Across New York State
  The session will review changes in federal regulations to methadone treatment for opioid use disorder, discuss data evaluating the impact of regulatory changes on the delivery of methadone treatment and on opioid use disorder outcomes, and present new strategies that leverage regulatory changes to expand methadone treatment for opioid use disorder.
• Imani Breakthrough Program: A Culturally-Attuned, Faith-Based Opioid Recovery Intervention for Black and LatinX Communities
  This session will discuss the Imani Breakthrough Project. Imani is a community delivered, faith-based, person-centered, culturally informed, harm reduction recovery program that provides an integrated approach to engaging Black and Latinx people and other vulnerable individuals to substance use supports, by focusing on dimensions of holistic health and wellness, reconnecting people to their sense of community, and by providing harm reduction and telemedicine and referrals for MAT.  Come learn about ways we can effectively collaborate with churches and people with lived/living experiences.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2.00 Credit(s)
• Nurses & NPs: 2.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): 0.5 Hour(s)
• PAs: 2.00 Credit(s)
• Pharmacists: 2.00 Credit(s)
• Interprofessional Continuing Education: 2.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2.00 Lifelong Learning
• ABIM MOC Points: 2.00 Medical Knowledge
• ABP MOC: 2.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2.00 Accredited CME | 2.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

The complete list of disclosures and designation statements are linked below.

Comorbidities

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Patients receiving addiction treatment frequently present with medical and psychological conditions that can greatly affect their overall well-being. This 1-hour, 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring disorders, such as HIV, hepatitis, infectious diseases, and stress and trauma.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Early Liver Transplantation for Severe Alcoholic Hepatitis
  The most common cause of liver failure requiring liver transplantation in the United States is excessive alcohol consumption. Without liver transplantation, patients with Alcohol Associated Hepatitis (AAH) that fail medical management have survival rates of ~30%. U.S. Transplant teams encountered substantial increases in the prevalence of AAH in younger, sicker patients with short sobriety subsequent to the COVID-19 Pandemic. This session will describe two new outpatient programs developed to improve treatment adherence and reduce relapse in this high-risk population; 1. "Total Recovery", a 12-week program exclusively for liver transplant patients with Alcohol Use Disorders; 2. "The Integrated Liver Transplant Engagement and Recovery Network (ILEARN)", an NIH-funded, co-located program for Post-Liver Transplant Management of Alcohol Use Disorders.
• Implementing a Peer-Supported, Integrated Strategy for Substance Use Disorder Care in an Outpatient Infectious Disease Clinic is Associated with Improved Patient Outcomes
  The RESTORE service (REcovery in Specialty care Through medication and OutREach) was established in January 2019 at Johns Hopkins Hospital in Baltimore City, Maryland, to improve access to SUD treatment and recovery services among patients with multiple comorbidities, including HIV and HCV. This session will describe the experiences and preliminary outcomes of a co-located substance use disorder (SUD) treatment and recovery service within an outpatient infectious disease specialty clinic. The presentation will cover the program funding, design, implementation and research findings. Despite the disruptions that COVID-19 pandemic caused, the high retention rates and low overdose risk observed in the multicomponent program demonstrated the effectiveness of the program.
• HIV & Addiction: Long-Acting Injectable Therapy for People with HIV
  This session will review long acting cabotegravir/rilpivirine (LA-CAB/RPV) including the drug classes, dosing, and administration. It will review the current evidence around its use in people who inject drugs (PWID) with comorbid HIV. The session will also describe in detail a current clinic's implementation of LA-CAB/RPV in PWID including in those not virally suppressed.
• The PROUD Study: Promoting Resilience for Medicaid Members with Opioid Use Disorder During Climate and Environmental Stressors
  This session will review findings of the PROUD (Promoting Resilience Among Medicaid Members with Opioid Use Disorder) study. This community partnered, participatory study assessed experiences of care for Medicaid members with opioid use disorder faced with environmental stressors such as hurricanes, floods, and pandemic surges. The presenter will review policy opportunities which may mitigate interruptions in care during major environmental stressors.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2.00 Credit(s)
• Nurses & NPs: 2.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): 0.5 Hour(s)
• PAs: 2.00 Credit(s)
• Pharmacists: 2.00 Credit(s)
• Interprofessional Continuing Education: 2.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2.00 Lifelong Learning
• ABIM MOC Points: 2.00 Medical Knowledge
• ABP MOC: 2.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2.00 Accredited CME | 2.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Initiation & Discontinuation

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Focusing on the complexities of initiation, this 2-hour, on-demand session from the 2024 ASAM State of the Art Course explores the critical phases of initiating and discontinuing addiction treatment, highlighting both established best practices and novel ways of implementing treatment interventions. Learners will review common challenges and learn about unique settings for induction.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Overcoming Challenges to Initiation of Extended-Release Naltrexone for Treating Opioid Use Disorder: Findings from the HEAL-Initiative NIDA Clinical Trials Network SWIFT Trial
  This session will provide an overview of the evidence regarding the effectiveness and safety of XR-naltrexone in the treatment of opioid use disorder. It will address the various challenges that community-based treatment programs face in implementing XR-naltrexone, including barriers related to patient initiation and provider training. Additionally, the presentation will describe a rapid initiation procedure for XR-naltrexone in patients actively using opioids, that has been shown to reduce the time to treatment initiation while maintaining safety and efficacy. This approach aims to improve access to and utilization of this important treatment option within community settings.
• Shared Decision-Making and Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: Practical Tools from the SWIFT Trial
  This session will cover the findings of the CTN-0097 SWIFT study, which demonstrated the effectiveness and safety of a rapid method of initiation of injection naltrexone among patients with opioid use disorder admitted to inpatient/residential treatment, using mainly non-opioid medications to combat withdrawal and low dose titration of oral naltrexone prior to naltrexone injection. This aims to make initiation of injection naltrexone more feasible within the timeframe of typical short-term inpatient stays. The session will also describe a shared decision-making tool developed for SWIFT to guide discussion between clinicians and patients about choice of medication treatment for opioid use disorder, encouraging initiation of one of the effective medications to reduce risk of relapse and overdose.
• Implementation Considerations for Emergency Department-Based Buprenorphine Induction for Opioid Use Disorder
  Emergency Departments are increasingly recognized as a unique touchpoint for patient access to treatment for opioid (OUD), although the provision of evidence-based treatments for OUD is underutilized. Innovations in formulations and approach to OUD medications for patients who can be safely transitioned to community partners are evolving, as are strategies to implement programs to provide OUD care. This session will review strategies and rationale for initiating buprenorphine in the emergency department including the use of high dose and injectable formulations, and review data from a recently completed nation-wide study of a 7-day injectable formulation. Strategies for implementing and building a program to evidence-based OUD care will be reviewed as well.
• Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies
  Most Americans live within 5 miles of a pharmacy, and pharmacists are highly skilled healthcare professionals who provide counseling and dispense life-saving medication—including buprenorphine and methadone--to patients on a daily basis. Pharmacists can administer injectable medications and can be trained to more actively support patients with substance use disorder. Nearly every state has the capacity to provide pharmacist collaborative care models or to adopt pharmacist-led models as a component of much needed expansions of the behavioral health workforce. This session will review key legal and policy structures surrounding pharmacy-based care, present results and implications from a trial of unobserved induction with buprenorphine in pharmacies and consider prospects for delivery models of pharmacy-based methadone for opioid use disorder in community pharmacies.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2 Credit(s)
• Nurses & NPs: 2 Nursing Contact Hour(s)
• Pharmacology Hour(s): 1.75 Hour(s)
• PAs: 2 Credit(s)
• Pharmacists: 2 Credit(s)
• Interprofessional Continuing Education: 2 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2 Lifelong Learning
• ABIM MOC Points: 2 Medical Knowledge
• ABP MOC: 2 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2 Accredited CME | 2 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.